Olga Brawman-Mintzer, M.D. | Psychiatrist.com

Original Research

Levetiracetam in Generalized Social Anxiety Disorder: A Double-Blind, Randomized Controlled Trial

December 15, 2009

Murray B. Stein, Lakshmi N. Ravindran, Naomi M. Simon, et al

Letter to the Editor

Dr. Brawman-Mintzer and Colleagues Reply to "Sedative Effects of Low-Dose Risperidone in GAD Patients and Risk of Drug Interactions"

August 1, 2006

Olga Brawman-Mintzer, Rebecca G. Knapp, Paul J. Nietert

Original Research

Sertraline Treatment for Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

June 15, 2006

Olga Brawman-Mintzer, Rebecca G. Knapp, Moira Rynn, et al

Original Research

Adjunctive Risperidone in Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study

October 14, 2005

Olga Brawman-Mintzer, Rebecca G. Knapp, Paul J. Nietert

Original Research

The Pharmacologic Treatment of Depression: Is Gender a Critical Factor?

July 16, 2002

Kimberly A. Yonkers, Olga Brawman-Mintzer

Original Research

Once-Weekly Dosing of Fluoxetine in the Maintenance of Remission in Panic Disorder

May 1, 1999

Naresh P. Emmanuel, Michael R. Ware, Olga Brawman-Mintzer, et al

Article

Anxious Depression

March 1, 1998

R. Bruce Lydiard, Olga Brawman-Mintzer

Article

Anxious Depression

March 1, 1998

R. Bruce Lydiard, Olga Brawman-Mintzer

Article

Biological Basis of Generalized Anxiety Disorder

March 1, 1997

Olga Brawman-Mintzer, R. Bruce Lydiard